Varda Space Industries

Varda Space Industries designs, manufactures, and operates autonomous spacecraft that facilitate pharmaceutical material production in low Earth orbit. The company's W-Series vehicles integrate a microgravity manufacturing module with a hypersonic reentry capsule to return products to Earth. Varda specializes in small-molecule drug crystallization, leveraging the absence of gravity to achieve formulations that are difficult or impossible to produce terrestrially. The company operates from El Segundo, California, and utilizes Rocket Lab's Photon spacecraft bus for its mission operations. Varda is the first commercial entity to receive an FAA Part 450 special vehicle operator license for reentries, successfully returning its inaugural W-1 mission to the Utah Test and Training Range in early 2024.

The company serves pharmaceutical and biotechnology firms through a manufacturing-as-a-service model and provides hypersonic testbed services for government agencies. Varda has conducted subsequent missions, including W-2 and W-3 in 2025, which involved payloads for the Air Force Research Laboratory and landings at the Koonibba Test Range in South Australia. These missions demonstrate the vehicle's capability as a low-cost, high-cadence platform for military hypersonic flight research and material science. Varda is a privately held corporation that continues to expand its orbital manufacturing infrastructure and international recovery operations.